| Bleeding complications of unfractionated heparin. | |
| | |
MedLine Citation:
|
PMID: 20868290 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Unfractionated heparin is an anticoagulant used in the treatment of myocardial infarction, pulmonary embolism and other thrombotic disorders. However, with anticoagulation comes the risk of bleeding and adverse events. These risks increase with supratherapeutic dosing. AREAS COVERED: In this review, we discuss the reasons for supratherapeutic dosing, and the incidence of adverse events and clinical consequences of the same, with a focus on heparin use in acute coronary syndromes. We also provide some opportunities for safer use of intravenous heparin. At the end of this article, the reader should have a better understanding of the proper use of heparin as well as the magnitude of bleeding and a respect for its consequences. EXPERT OPINION: Heparin is an indispensable anticoagulant used in a number of clinical scenarios. Careful attention must be paid to dosing in order to minimize the risk of bleeding and related adverse events including death. The use of weight-based nomograms is paramount. Devices to automate testing and titration are currently under development. |
| | |
Authors:
|
Amar Krishnaswamy; A Michael Lincoff; Christopher P Cannon |
Publication Detail:
|
Type: Journal Article; Review Date: 2010-09-25 |
Journal Detail:
|
Title: Expert opinion on drug safety Volume: 10 ISSN: 1744-764X ISO Abbreviation: Expert Opin Drug Saf Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2010-12-16 Completed Date: 2011-03-31 Revised Date: 2013-05-20 |
Medline Journal Info:
|
Nlm Unique ID: 101163027 Medline TA: Expert Opin Drug Saf Country: England |
Other Details:
|
Languages: eng Pagination: 77-84 Citation Subset: IM |
Affiliation:
|
Cleveland Clinic, Division of Cardiovascular Medicine, Cleveland, OH 44115, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anticoagulants
/
administration & dosage,
adverse effects* Hemorrhage / chemically induced*, prevention & control Heparin / administration & dosage, adverse effects* Humans Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 9005-49-6/Heparin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Thyroid hormones, their carrier proteins, and thyroid antibodies in the pleural effusion of two pati...
Next Document: Nalmefene for treatment of alcohol dependence.